Acadia Pharmaceuticals | Nettoeinkommen



Net Income Veränderung Datum
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
ALKERMES USD 22.46M 344.61M 2025-03
Alnylam Pharmaceuticals USD -57479000 26.28M 2025-03
Biogen USD 240.5M 26.2M 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Corcept Therapeutics USD 20.55M 10.2M 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Eisai JPY 949M 22.84B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Incyte USD 158.2M 43.01M 2025-03
J&J USD 11B 7.57B 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Prothena USD -57956000 1.04M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Sarepta Therapeutics USD -447508000 606.56M 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Acadia Pharmaceuticals Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.